JOY BROYLES: Open Payments
NPI 1679877328 · DECATUR, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,322 in 107 payments from 31 companies in 2025. Trend: 2023 $1,750 · 2024 $1,378 · 2025 $3,322
Food & beverage: $3,163Education: $159
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $356 |
| Daiichi Sankyo Inc. | 4 | $291 |
| GENZYME CORPORATION | 7 | $269 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $224 |
| Novartis Pharmaceuticals Corporation | 11 | $216 |
| Astellas Pharma US Inc | 5 | $188 |
| GlaxoSmithKline, LLC. | 4 | $174 |
| ABBVIE INC. | 11 | $169 |
| Merck Sharp & Dohme LLC | 6 | $141 |
| BeOne Medicines USA, Inc. | 6 | $129 |
Products named: SARCLISA, RYBREVANT, ERLEADA, FRUZAQLA, KEYTRUDA, Fabhalta, MYRISK, OPDIVO.
Industry payments across GA — which companies pay providers there.
